“PARP Inhibitors in Newly Diagnosed or Recurrent Ovarian Cancer Maintenance Therapy: Evidence of Efficacy and Safety from Randomized Controlled Trials”. 2023. Biomedical Research and Therapy 10 (12): 6090-6102. https://doi.org/10.15419/bmrat.v10i12.851.